Eli Lilly and Novo Nordisk getting hit as President Biden says they’re “ripping off Americans”. 

The rising costs of weight loss drugs, and the political impact on the pharma space. Plus Tesla charges higher. The EV maker reporting strong delivery numbers, extending the stock’s recent win streak. But could shares be nearing a key resistance level? How the technicals are looking in this name.

Fast Money Disclaimer